CFS
FLGT icon

CGC Financial Services’s Fulgent Genetics FLGT Stock Holding History

CGC Financial Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-53
Closed -$1.96K – 350
2023
Q2 		$1.96K Buy
+53
New +$1.85K ﹤0.01% 267

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CGC Financial Services's FLGT Position: Q3 2023 in Review

CGC Financial Services sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 53 shares — an estimated $1.96K sold.

CGC Financial Services first reported a position in FLGT in Q2 2023 and held it in 1 quarter. The position peaked at $1.96K in Q2 2023. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • CGC Financial Services reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • CGC Financial Services sold 53 Fulgent Genetics shares in Q3 2023, an estimated $1.96K.
  • CGC Financial Services first reported a position in Fulgent Genetics in Q2 2023 and held it in 1 quarter.
  • CGC Financial Services's Fulgent Genetics position peaked at $1.96K in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on CGC Financial Services's 13F filing for Q3 2023, filed 25 Oct 2023.